StockWatch
·

Jubilant Pharmova Ltd Q2 FY27 Results

JUBLPHARMAQ2 FY27 Results
Filing
Result:Weak· Market: Flat#Margin squeeze#Cost led
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue2.4K6.3%20.5%
Total Income2.4K6.0%20.7%
Expenditure2.3K7.4%30.5%
PBT61.7028.6%67.6%
Net Profit31.0045.0%74.2%
OPM10.15%0.97pp6.92pp
NPM1.30%1.21pp4.77pp
EPS1.9744.8%74.0%
View full financials

Revenue grew 20.5% YoY but adjusted PAT collapsed 74% as costs outpaced sales, compressing OPM to 10.15% from 17.07% and NPM to 1.30% from 6.07% — a clear below-par quarter for the pharma sector despite top-line growth.

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue2.4K6.3%20.5%
Total Income2.4K6.0%20.7%
Expenditure2.3K7.4%30.5%
PBT61.7028.6%67.6%
Net Profit31.0045.0%74.2%
OPM10.15%0.97pp6.92pp
NPM1.30%1.21pp4.77pp
EPS1.9744.8%74.0%
View full financials

Detailed report is being prepared.

Informational and educational content only. Not investment advice.